Literature DB >> 19203807

Kounis syndrome: two extraordinary cases.

George Almpanis, Simos Siahos, Nicholas C Karogiannis, Andreas Mazarakis, Constantinos Niarchos, George N Kounis, Nicholas G Kounis.   

Abstract

Acute myocardial infarction occurring during the course of an allergic reaction constitutes the Kounis syndrome. This syndrome is caused by inflammatory mediators released mainly from activated mast cells and the interrelated via bidirectional stimuli macrophages and T-lymphocytes. Since activated mast cells abound at the areas of plaque erosion or rupture in patients suffering from acute myocardial infarction a common pathway between allergic and non allergic coronary events seems to exist. Two cases of this syndrome are described, the first following nicorette transdermal application and subsequent finger pricking by fish bone and the second after ciprofloxacin administration.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203807     DOI: 10.1016/j.ijcard.2009.01.031

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Asymptomatic acute myocardial injury during allergic reaction to hymenoptera venom.

Authors:  Christian Leli
Journal:  Intern Emerg Med       Date:  2011-03-23       Impact factor: 3.397

2.  Acute cardiogenic shock induced by infusional 5-Fluorouracil.

Authors:  Jeffrey Sulpher; Franco Dattilo; Susan Dent; Michele Turek; M Neil Reaume; Christopher Johnson
Journal:  Case Rep Oncol Med       Date:  2014-10-28

3.  A Case with Repeated Recurrent Acute Coronary Syndrome due to Pseudoephedrine Use: Kounis Syndrome.

Authors:  Metin Celiker; Mustafa Tuncer; Ali Sekeralmaz
Journal:  Case Rep Med       Date:  2014-11-11

4.  Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.

Authors:  Alberto Navarro-Navajas; Ingrid Casallas; Daniel Isaza; Paola Ortiz; Daniela Baracaldo-Santamaría; Carlos-Alberto Calderon-Ospina
Journal:  Medicina (Kaunas)       Date:  2022-06-26       Impact factor: 2.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.